Financial Performance Overview

Max Healthcare Institute Limited reported strong financial results for FY 2025-26 with revenue from operations reaching ₹8,373 crore, representing 19.1% growth year-on-year. Net profit after tax surged 34% to ₹1,442 crore, while PBIDT increased 20% to ₹2,405 crore with margins expanding to 28.2%. Basic EPS stood at ₹14.83 per share. The Board recommended a final dividend of ₹2 per equity share (20% of face value), subject to shareholder approval at the upcoming AGM.

Operational Expansion and Growth Initiatives

The company significantly expanded its capacity during FY26, adding over 1,200 beds across key facilities including Mohali (160 beds), Mumbai Nanavati (280 beds), and partially commissioning a 400-bed tower at Saket. Major acquisitions included a 58.28% controlling stake in Kalinga Hospital (250-bed Bhubaneswar facility) for ₹297.97 crore and agreements for new hospitals in Pune (450 beds), Dehradun (130 beds), and Lucknow (712-bed greenfield project).

25th Annual General Meeting Details

Max Healthcare will hold its 25th AGM on July 30, 2026, with key agenda items including:

  • Declaration of final dividend of ₹2 per share
  • Re-appointment of Director Anil Kumar Bhatnagar with increased remuneration to ₹40 lakh annually
  • Approval to shift registered office from Maharashtra to Haryana
  • Ratification of cost auditor remuneration of ₹10.42 lakh plus taxes
  • Increase in non-executive director remuneration limits

ESG and Sustainability Performance

The company demonstrated strong ESG performance with comprehensive initiatives including:

  • 24% renewable energy consumption (90,869 GJ, 62% YoY increase)
  • 90% waste diversion from landfills through recycling and circular practices
  • Water intensity reduction to 0.00118 megalitres per bed per day (4% YoY)
  • TCFD-aligned climate risk assessment covering 43 assets
  • Multiple IGBC Gold and GRIHA certified green buildings
  • 52% wastewater recycling rate

Financial Risk Management and Capital Structure

The company maintained a conservative capital structure with debt-to-equity ratio of 0.32 and net debt-to-EBITDA of 1.25. Interest rate sensitivity analysis showed a ₹1,397 lakh impact on profit before tax for a 0.5% rate change. Borrowings included ₹10,850 lakhs from related party Hometrail Buildtech at 9.25% interest and various bank facilities.

Employee Benefits and Stock Options

Post-employment benefit obligations totaled ₹844 lakhs with net expense of ₹82 lakhs. The Group granted 8,15,408 employee stock options under MHIL ESOP 2022 Scheme with fair value expense of ₹4,833 lakhs recognized in profit and loss. Key management personnel remuneration amounted to ₹3,665 lakhs.

Corporate Governance and Compliance

The company maintained robust corporate governance with 8 directors (including 5 independent directors), 91.67% average board attendance, and no penalties on directors/KMPs. All statutory compliances were maintained with unmodified audit opinions from S.R. Batliboi & Co. LLP. Unclaimed dividends totaled ₹54.04 lakh for FY22-25 with 458,120 equity shares in suspense account.

Contingent Liabilities and Commitments

Contingent liabilities stood at ₹13,378 lakhs including civil cases (₹11,693 lakhs) and indirect tax matters (₹1,678 lakhs). Capital commitments totaled ₹35,039 lakhs net of advances, while corporate guarantees given amounted to ₹2,67,229 lakhs to financial institutions and third parties.

Related Party Transactions and Balances

Significant related party transactions included loans from Hometrail Buildtech (₹10,850 lakhs), balances with entities controlled by Chairman Abhay Soi (₹19 lakhs trade payable), and dividend income from subsidiaries of ₹7,156 lakhs. All transactions were conducted on arm's length basis.

Regulatory Framework and Compliance

The company complied with SEBI Listing Regulations, Companies Act 2013 requirements, and various regulatory frameworks including GRI Standards, TCFD recommendations, and IFRS S2 for sustainability disclosures. The integrated annual report incorporated all mandatory disclosures under applicable accounting standards and regulatory requirements.